Citation 139010

YESILADA,E: USTUN,O: SEZIK,E: TAKAISHI,Y: ONO,Y: HONDA,G:. (1997). INHIBITORY EFFECTS OF TURKISH FOLK REMEDIES ON INFLAMMATORY CYTOKINES: INTERLEUKIN-1 ALPHA, INTERLEUKIN-1 BETA AND TUMOR NECROSIS FACTOR ALPHA.. 58(1)

Citation Details

TitleINHIBITORY EFFECTS OF TURKISH FOLK REMEDIES ON INFLAMMATORY CYTOKINES: INTERLEUKIN-1 ALPHA, INTERLEUKIN-1 BETA AND TUMOR NECROSIS FACTOR ALPHA.
AuthorsYESILADA,E: USTUN,O: SEZIK,E: TAKAISHI,Y: ONO,Y: HONDA,G:
Year1997
Volume58
Issue1

Summary

Year: 1997

Journal: Unknown

Organisms and Their Experiments (14)

Cistus laurifolius (CISTACEAE)

Experiment #Pharmacology TypeWorktypesCompoundResults
1Not specified NoneNone
2
ANALGESIC ACTIVITY
NoneNone
3
ANTIPYRETIC ACTIVITY
NoneNone
4
ANTIINFLAMMATORY ACTIVITY
NoneNone
5
INTERLEUKIN-1-ALPHA RELEASE INHIBITION
None
WEAK ACTIVITY
6
INTERLEUKIN-1-BETA RELEASE INHIBITION
None
WEAK ACTIVITY
7
TUMOR NECROSING FACTOR INHIBITION
None
INACTIVE
8
INTERLEUKIN-1-ALPHA RELEASE INHIBITION
None
WEAK ACTIVITY
9
INTERLEUKIN-1-BETA RELEASE INHIBITION
None
INACTIVE
10
TUMOR NECROSING FACTOR INHIBITION
None
INACTIVE
11
INTERLEUKIN-1-ALPHA RELEASE INHIBITION
None
ACTIVE
12
INTERLEUKIN-1-BETA RELEASE INHIBITION
None
WEAK ACTIVITY
13
TUMOR NECROSING FACTOR INHIBITION
None
INACTIVE
14
INTERLEUKIN-1-ALPHA RELEASE INHIBITION
None
ACTIVE
15
INTERLEUKIN-1-BETA RELEASE INHIBITION
None
WEAK ACTIVITY
16
TUMOR NECROSING FACTOR INHIBITION
None
INACTIVE
17
INTERLEUKIN-1-ALPHA RELEASE INHIBITION
None
WEAK ACTIVITY
18
INTERLEUKIN-1-BETA RELEASE INHIBITION
None
WEAK ACTIVITY
19
TUMOR NECROSING FACTOR INHIBITION
None
INACTIVE

Cistus laurifolius (CISTACEAE)

Experiment #Pharmacology TypeWorktypesCompoundResults
1Not specified NoneNone
2
ANTIULCER ACTIVITY
NoneNone

Clematis flammula (RANUNCULACEAE)

Experiment #Pharmacology TypeWorktypesCompoundResults
1Not specified NoneNone
2
DIURETIC ACTIVITY
NoneNone
3
INTERLEUKIN-1-ALPHA RELEASE INHIBITION
None
WEAK ACTIVITY
4
INTERLEUKIN-1-BETA RELEASE INHIBITION
None
WEAK ACTIVITY
5
TUMOR NECROSING FACTOR INHIBITION
None
WEAK ACTIVITY
6
INTERLEUKIN-1-ALPHA RELEASE INHIBITION
None
INACTIVE
7
INTERLEUKIN-1-BETA RELEASE INHIBITION
None
INACTIVE
8
TUMOR NECROSING FACTOR INHIBITION
None
WEAK ACTIVITY
9
INTERLEUKIN-1-ALPHA RELEASE INHIBITION
None
WEAK ACTIVITY
10
INTERLEUKIN-1-BETA RELEASE INHIBITION
None
WEAK ACTIVITY
11
TUMOR NECROSING FACTOR INHIBITION
None
WEAK ACTIVITY
12
INTERLEUKIN-1-ALPHA RELEASE INHIBITION
None
WEAK ACTIVITY
13
INTERLEUKIN-1-BETA RELEASE INHIBITION
None
INACTIVE
14
TUMOR NECROSING FACTOR INHIBITION
None
WEAK ACTIVITY

Crataegus tanacetifolia (ROSACEAE)

Experiment #Pharmacology TypeWorktypesCompoundResults
1Not specified NoneNone
2
ANALGESIC ACTIVITY
NoneNone
3
INTERLEUKIN-1-ALPHA RELEASE INHIBITION
None
INACTIVE
4
INTERLEUKIN-1-BETA RELEASE INHIBITION
None
INACTIVE
5
TUMOR NECROSING FACTOR INHIBITION
None
WEAK ACTIVITY
6
INTERLEUKIN-1-ALPHA RELEASE INHIBITION
None
ACTIVE
7
INTERLEUKIN-1-BETA RELEASE INHIBITION
None
ACTIVE
8
TUMOR NECROSING FACTOR INHIBITION
None
WEAK ACTIVITY
9
INTERLEUKIN-1-ALPHA RELEASE INHIBITION
None
INACTIVE
10
INTERLEUKIN-1-BETA RELEASE INHIBITION
None
WEAK ACTIVITY
11
TUMOR NECROSING FACTOR INHIBITION
None
WEAK ACTIVITY
12
INTERLEUKIN-1-ALPHA RELEASE INHIBITION
None
INACTIVE
13
INTERLEUKIN-1-BETA RELEASE INHIBITION
None
WEAK ACTIVITY
14
TUMOR NECROSING FACTOR INHIBITION
None
WEAK ACTIVITY
15
INTERLEUKIN-1-ALPHA RELEASE INHIBITION
None
ACTIVE
16
INTERLEUKIN-1-BETA RELEASE INHIBITION
None
WEAK ACTIVITY
17
TUMOR NECROSING FACTOR INHIBITION
None
WEAK ACTIVITY

Crataegus orientalis (ROSACEAE)

Experiment #Pharmacology TypeWorktypesCompoundResults
1Not specified NoneNone
2
ANTIINFLAMMATORY ACTIVITY
NoneNone

Daphne oleoides (THYMELAEACEAE)

Experiment #Pharmacology TypeWorktypesCompoundResults
1Not specified NoneNone
2
ANTISPASMODIC ACTIVITY(UNSPECIFIED TYPE)
NoneNone
3
ANTICONVULSANT ACTIVITY
NoneNone
4
ANTIPYRETIC ACTIVITY
NoneNone
5
ANTIINFLAMMATORY ACTIVITY
NoneNone
6
ANTIINFLAMMATORY ACTIVITY
NoneNone
7
ANTIEDEMA ACTIVITY
NoneNone
8
ANTIMALARIAL ACTIVITY
NoneNone
9
INTERLEUKIN-1-ALPHA RELEASE INHIBITION
None
ACTIVE
10
INTERLEUKIN-1-BETA RELEASE INHIBITION
None
WEAK ACTIVITY
11
TUMOR NECROSING FACTOR INHIBITION
None
ACTIVE
12
INTERLEUKIN-1-ALPHA RELEASE INHIBITION
None
WEAK ACTIVITY
13
INTERLEUKIN-1-BETA RELEASE INHIBITION
None
INACTIVE
14
TUMOR NECROSING FACTOR INHIBITION
None
ACTIVE
15
INTERLEUKIN-1-ALPHA RELEASE INHIBITION
None
ACTIVE
16
INTERLEUKIN-1-BETA RELEASE INHIBITION
None
WEAK ACTIVITY
17
TUMOR NECROSING FACTOR INHIBITION
None
ACTIVE
18
INTERLEUKIN-1-ALPHA RELEASE INHIBITION
None
ACTIVE
19
INTERLEUKIN-1-BETA RELEASE INHIBITION
None
WEAK ACTIVITY
20
TUMOR NECROSING FACTOR INHIBITION
None
ACTIVE
21
INTERLEUKIN-1-ALPHA RELEASE INHIBITION
None
WEAK ACTIVITY
22
INTERLEUKIN-1-BETA RELEASE INHIBITION
None
INACTIVE
23
TUMOR NECROSING FACTOR INHIBITION
None
WEAK ACTIVITY

Ecballium elaterium (CUCURBITACEAE)

Experiment #Pharmacology TypeWorktypesCompoundResults
1Not specified NoneNone
2
ANTIINFLAMMATORY ACTIVITY
NoneNone
3
ANTIJAUNDICE EFFECT
NoneNone
4
ANTIINFLAMMATORY ACTIVITY
NoneNone
5
INTERLEUKIN-1-ALPHA RELEASE INHIBITION
None
WEAK ACTIVITY
6
INTERLEUKIN-1-BETA RELEASE INHIBITION
None
WEAK ACTIVITY
7
TUMOR NECROSING FACTOR INHIBITION
None
WEAK ACTIVITY
8
INTERLEUKIN-1-ALPHA RELEASE INHIBITION
None
WEAK ACTIVITY
9
INTERLEUKIN-1-BETA RELEASE INHIBITION
None
INACTIVE
10
TUMOR NECROSING FACTOR INHIBITION
None
WEAK ACTIVITY
11
INTERLEUKIN-1-ALPHA RELEASE INHIBITION
None
ACTIVE
12
INTERLEUKIN-1-BETA RELEASE INHIBITION
None
ACTIVE
13
TUMOR NECROSING FACTOR INHIBITION
None
ACTIVE
14
INTERLEUKIN-1-ALPHA RELEASE INHIBITION
None
WEAK ACTIVITY
15
INTERLEUKIN-1-BETA RELEASE INHIBITION
None
WEAK ACTIVITY
16
TUMOR NECROSING FACTOR INHIBITION
None
WEAK ACTIVITY
17
INTERLEUKIN-1-ALPHA RELEASE INHIBITION
None
WEAK ACTIVITY
18
INTERLEUKIN-1-BETA RELEASE INHIBITION
None
WEAK ACTIVITY
19
TUMOR NECROSING FACTOR INHIBITION
None
WEAK ACTIVITY

Rosa canina (ROSACEAE)

Experiment #Pharmacology TypeWorktypesCompoundResults
1Not specified NoneNone
2
ANTIBURN EFFECT
NoneNone
3
ANTIDIARRHEAL ACTIVITY
NoneNone
4
CARDIOTONIC ACTIVITY
NoneNone
5
ANTIINFLAMMATORY ACTIVITY
NoneNone
6
ANTITUSSIVE ACTIVITY
NoneNone
7
BRONCHODILATOR ACTIVITY
NoneNone
8
ANTIHEMORRHOIDAL ACTIVITY
NoneNone
9
MISCELLANEOUS EFFECTS
NoneNone
10
ANTITUSSIVE ACTIVITY
NoneNone
11
HYPERGLYCEMIC ACTIVITY
NoneNone
12
ANTIBACTERIAL ACTIVITY
NoneNone
13
KIDNEY STONE DISSOLUTION EFFECT
NoneNone
14
ANTIECZEMA EFFECT
NoneNone
15
INTERLEUKIN-1-ALPHA RELEASE INHIBITION
None
ACTIVE
16
INTERLEUKIN-1-BETA RELEASE INHIBITION
None
WEAK ACTIVITY
17
TUMOR NECROSING FACTOR INHIBITION
None
WEAK ACTIVITY
18
INTERLEUKIN-1-ALPHA RELEASE INHIBITION
None
WEAK ACTIVITY
19
INTERLEUKIN-1-BETA RELEASE INHIBITION
None
WEAK ACTIVITY
20
TUMOR NECROSING FACTOR INHIBITION
None
WEAK ACTIVITY
21
INTERLEUKIN-1-ALPHA RELEASE INHIBITION
None
ACTIVE
22
INTERLEUKIN-1-BETA RELEASE INHIBITION
None
ACTIVE
23
TUMOR NECROSING FACTOR INHIBITION
None
WEAK ACTIVITY
24
INTERLEUKIN-1-ALPHA RELEASE INHIBITION
None
WEAK ACTIVITY
25
INTERLEUKIN-1-BETA RELEASE INHIBITION
None
WEAK ACTIVITY
26
TUMOR NECROSING FACTOR INHIBITION
None
WEAK ACTIVITY

Rubus discolor (ROSACEAE)

Experiment #Pharmacology TypeWorktypesCompoundResults
1Not specified NoneNone
2
INTERLEUKIN-1-ALPHA RELEASE INHIBITION
None
WEAK ACTIVITY
3
INTERLEUKIN-1-BETA RELEASE INHIBITION
None
WEAK ACTIVITY
4
TUMOR NECROSING FACTOR INHIBITION
None
INACTIVE
5
INTERLEUKIN-1-ALPHA RELEASE INHIBITION
None
INACTIVE
6
INTERLEUKIN-1-BETA RELEASE INHIBITION
None
WEAK ACTIVITY
7
TUMOR NECROSING FACTOR INHIBITION
None
WEAK ACTIVITY
8
INTERLEUKIN-1-ALPHA RELEASE INHIBITION
None
WEAK ACTIVITY
9
INTERLEUKIN-1-BETA RELEASE INHIBITION
None
INACTIVE
10
TUMOR NECROSING FACTOR INHIBITION
None
WEAK ACTIVITY
11
INTERLEUKIN-1-ALPHA RELEASE INHIBITION
None
WEAK ACTIVITY
12
INTERLEUKIN-1-BETA RELEASE INHIBITION
None
ACTIVE
13
TUMOR NECROSING FACTOR INHIBITION
None
INACTIVE

Rubus hirtus (ROSACEAE)

Experiment #Pharmacology TypeWorktypesCompoundResults
1Not specified NoneNone
2
ANTIBACTERIAL ACTIVITY
NoneNone
3
HEMOSTATIC ACTIVITY
NoneNone
4
ANTIDIARRHEAL ACTIVITY
NoneNone
5
ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY
NoneNone
6
MISCELLANEOUS EFFECTS
NoneNone
7
KIDNEY STONE DISSOLUTION EFFECT
NoneNone
8
PSORIASIS TREATMENT
NoneNone
9
ANTIINFLAMMATORY ACTIVITY
NoneNone
10
CNS EFFECTS(GENERAL)
NoneNone
11
ANTIHEMORRHOIDAL ACTIVITY
NoneNone
12
ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY
NoneNone
13
INTERLEUKIN-1-ALPHA RELEASE INHIBITION
None
INACTIVE
14
INTERLEUKIN-1-BETA RELEASE INHIBITION
None
WEAK ACTIVITY
15
TUMOR NECROSING FACTOR INHIBITION
None
INACTIVE
16
INTERLEUKIN-1-ALPHA RELEASE INHIBITION
None
WEAK ACTIVITY
17
INTERLEUKIN-1-BETA RELEASE INHIBITION
None
WEAK ACTIVITY
18
TUMOR NECROSING FACTOR INHIBITION
None
WEAK ACTIVITY
19
INTERLEUKIN-1-ALPHA RELEASE INHIBITION
None
WEAK ACTIVITY
20
INTERLEUKIN-1-BETA RELEASE INHIBITION
None
INACTIVE
21
TUMOR NECROSING FACTOR INHIBITION
None
WEAK ACTIVITY
22
INTERLEUKIN-1-ALPHA RELEASE INHIBITION
None
WEAK ACTIVITY
23
INTERLEUKIN-1-BETA RELEASE INHIBITION
None
INACTIVE
24
TUMOR NECROSING FACTOR INHIBITION
None
ACTIVE

Sambucus ebulus (CAPRIFOLIACEAE)

Experiment #Pharmacology TypeWorktypesCompoundResults
1Not specified NoneNone
2
ANTIECZEMA EFFECT
NoneNone
3
ANTIINFLAMMATORY ACTIVITY
NoneNone
4
ANTIINFLAMMATORY ACTIVITY
NoneNone
5
ANALGESIC ACTIVITY
NoneNone
6
ANALGESIC ACTIVITY
NoneNone
7
ANTIBACTERIAL ACTIVITY
NoneNone
8
ANTIVENIN EFFECT
NoneNone
9
ANTIHEMORRHOIDAL ACTIVITY
NoneNone
10
INTERLEUKIN-1-ALPHA RELEASE INHIBITION
None
ACTIVE
11
INTERLEUKIN-1-BETA RELEASE INHIBITION
None
ACTIVE
12
TUMOR NECROSING FACTOR INHIBITION
None
INACTIVE
13
INTERLEUKIN-1-ALPHA RELEASE INHIBITION
None
WEAK ACTIVITY
14
INTERLEUKIN-1-BETA RELEASE INHIBITION
None
WEAK ACTIVITY
15
TUMOR NECROSING FACTOR INHIBITION
None
INACTIVE
16
INTERLEUKIN-1-ALPHA RELEASE INHIBITION
None
WEAK ACTIVITY
17
INTERLEUKIN-1-BETA RELEASE INHIBITION
None
ACTIVE
18
TUMOR NECROSING FACTOR INHIBITION
None
ACTIVE
19
INTERLEUKIN-1-ALPHA RELEASE INHIBITION
None
WEAK ACTIVITY
20
INTERLEUKIN-1-BETA RELEASE INHIBITION
None
WEAK ACTIVITY
21
TUMOR NECROSING FACTOR INHIBITION
None
WEAK ACTIVITY
22
INTERLEUKIN-1-ALPHA RELEASE INHIBITION
None
WEAK ACTIVITY
23
INTERLEUKIN-1-BETA RELEASE INHIBITION
None
WEAK ACTIVITY
24
TUMOR NECROSING FACTOR INHIBITION
None
WEAK ACTIVITY

Sambucus ebulus (CAPRIFOLIACEAE)

Experiment #Pharmacology TypeWorktypesCompoundResults
1Not specified NoneNone
2
INTERLEUKIN-1-ALPHA RELEASE INHIBITION
None
WEAK ACTIVITY
3
INTERLEUKIN-1-BETA RELEASE INHIBITION
None
WEAK ACTIVITY
4
TUMOR NECROSING FACTOR INHIBITION
None
WEAK ACTIVITY
5
INTERLEUKIN-1-ALPHA RELEASE INHIBITION
None
WEAK ACTIVITY
6
INTERLEUKIN-1-BETA RELEASE INHIBITION
None
INACTIVE
7
TUMOR NECROSING FACTOR INHIBITION
None
INACTIVE
8
INTERLEUKIN-1-ALPHA RELEASE INHIBITION
None
WEAK ACTIVITY
9
INTERLEUKIN-1-BETA RELEASE INHIBITION
None
WEAK ACTIVITY
10
TUMOR NECROSING FACTOR INHIBITION
None
INACTIVE
11
INTERLEUKIN-1-ALPHA RELEASE INHIBITION
None
WEAK ACTIVITY
12
INTERLEUKIN-1-BETA RELEASE INHIBITION
None
WEAK ACTIVITY
13
TUMOR NECROSING FACTOR INHIBITION
None
WEAK ACTIVITY
14
INTERLEUKIN-1-ALPHA RELEASE INHIBITION
None
INACTIVE
15
INTERLEUKIN-1-BETA RELEASE INHIBITION
None
INACTIVE
16
TUMOR NECROSING FACTOR INHIBITION
None
INACTIVE

Sambucus nigra (CAPRIFOLIACEAE)

Experiment #Pharmacology TypeWorktypesCompoundResults
1Not specified NoneNone
2
INTERLEUKIN-1-ALPHA RELEASE INHIBITION
None
WEAK ACTIVITY
3
INTERLEUKIN-1-BETA RELEASE INHIBITION
None
WEAK ACTIVITY
4
TUMOR NECROSING FACTOR INHIBITION
None
ACTIVE
5
INTERLEUKIN-1-ALPHA RELEASE INHIBITION
None
INACTIVE
6
INTERLEUKIN-1-BETA RELEASE INHIBITION
None
INACTIVE
7
TUMOR NECROSING FACTOR INHIBITION
None
ACTIVE
8
INTERLEUKIN-1-ALPHA RELEASE INHIBITION
None
INACTIVE
9
INTERLEUKIN-1-BETA RELEASE INHIBITION
None
WEAK ACTIVITY
10
TUMOR NECROSING FACTOR INHIBITION
None
WEAK ACTIVITY
11
INTERLEUKIN-1-ALPHA RELEASE INHIBITION
None
INACTIVE
12
INTERLEUKIN-1-BETA RELEASE INHIBITION
None
WEAK ACTIVITY
13
TUMOR NECROSING FACTOR INHIBITION
None
ACTIVE
14
INTERLEUKIN-1-ALPHA RELEASE INHIBITION
None
INACTIVE
15
INTERLEUKIN-1-BETA RELEASE INHIBITION
None
INACTIVE
16
TUMOR NECROSING FACTOR INHIBITION
None
ACTIVE

Sambucus nigra (CAPRIFOLIACEAE)

Experiment #Pharmacology TypeWorktypesCompoundResults
1Not specified NoneNone
2
ANTIINFLAMMATORY ACTIVITY
NoneNone
3
ANTIBACTERIAL ACTIVITY
NoneNone
4
BENIGN PROSTATIC HYPERPLASIA IMPROVEMENT
NoneNone
5
ANTIHEMORRHOIDAL ACTIVITY
NoneNone
6
INTERLEUKIN-1-ALPHA RELEASE INHIBITION
None
ACTIVE
7
INTERLEUKIN-1-BETA RELEASE INHIBITION
None
ACTIVE
8
TUMOR NECROSING FACTOR INHIBITION
None
ACTIVE
9
INTERLEUKIN-1-ALPHA RELEASE INHIBITION
None
WEAK ACTIVITY
10
INTERLEUKIN-1-BETA RELEASE INHIBITION
None
WEAK ACTIVITY
11
TUMOR NECROSING FACTOR INHIBITION
None
WEAK ACTIVITY
12
INTERLEUKIN-1-ALPHA RELEASE INHIBITION
None
WEAK ACTIVITY
13
INTERLEUKIN-1-BETA RELEASE INHIBITION
None
ACTIVE
14
TUMOR NECROSING FACTOR INHIBITION
None
WEAK ACTIVITY
15
INTERLEUKIN-1-ALPHA RELEASE INHIBITION
None
WEAK ACTIVITY
16
INTERLEUKIN-1-BETA RELEASE INHIBITION
None
ACTIVE
17
TUMOR NECROSING FACTOR INHIBITION
None
ACTIVE
18
INTERLEUKIN-1-ALPHA RELEASE INHIBITION
None
WEAK ACTIVITY
19
INTERLEUKIN-1-BETA RELEASE INHIBITION
None
INACTIVE
20
TUMOR NECROSING FACTOR INHIBITION
None
INACTIVE